ARCHIVES

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

March 28, 2003

Martha Fewell, Assistant To NCI Directors, To Retire

May 3, 2002

Young Takes Over Centers & Community Oncology, Says Biggest Problem Is Getting Adequate Funds

April 8, 1988

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

Cooperative Group Trials Approved By NCI Are Listed

August 26, 2005